objective assess outcomes proton beam radiotherapy treatment uveal melanomas patients specifically referred university california san francisco ocular conservation therapy series patients uniformly refused enucleation outside institution treatment option extensive discussion university california san francisco design retrospective nonrandomized cohort study NUMBER patients choroidal ciliochoroidal melanomas measuring NUMBER mm maximum thickness NUMBER mm maximum basal diameter tumors located NUMBER mm optic nerve measuring NUMBER mm maximum thickness NUMBER mm maximum basal diameter met inclusion criteria main outcome measures frequency NUMBER anterior segment complications lash loss keratopathy cataract neovascular glaucoma NUMBER posterior segment complications vitreous hemorrhage radiation retinopathy radiation papillopathy NUMBER treatment failure tumor growth enucleation metastases NUMBER final visual acuity results median NUMBER months mean age treatment NUMBER years frequencies hypertension diabetes mellitus NUMBER NUMBER respectively mean tumor thickness mean basal diameter NUMBER mm NUMBER mm respectively lash loss occurred NUMBER dry eye NUMBER cataract NUMBER neovascular glaucoma NUMBER NUMBER patients diabetes mellitus radiation retinopathy NUMBER radiation papillopathy NUMBER patient developed scleral necrosis vitreous hemorrhage kaplanmeier estimate local tumor growth treatment NUMBER rate distant metastasis NUMBER visual acuity better preserved NUMBER patients including NUMBER patients NUMBER experienced average NUMBER lines snellen visual acuity improvement development neovascular glaucoma associated tumors close proximity optic nerve p NUMBER cataract p NUMBER lash loss p NUMBER occurred anteriorly located tumors proton beam radiotherapy provided NUMBER probability local control NUMBER probability clinically discernible survival NUMBER months treatment conclusion proton beam radiotherapy option considered treatment uveal melanoma carefully selected patients extra large extra large follow radiation associated NUMBER year metastases free ocular conserving extra large NUMBER NUMBER